MDLN

Medline Inc. Class A Common Stock (MDLN)

Stock · NASDAQ · Health Care

$35.96as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Medline expands Midwest network and signs pediatric deal. Medline is expanding its Midwestern distribution network with a new 800,000-square-foot facility in Michigan. The company also secured a prime vendor agreement to support ten pediatric care locations in South Carolina and launched an enhanced inventory management system. These operational developments occur alongside market analysis regarding the company's private equity ownership structure.

Price chart

Open in TradingView

Active signals

Support Confirmation22.8%200 SMA Touch0.0%
Support level
$34.51
Industry
Medical/Dental Instruments

About MDLN

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and labora…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
45,000

Fundamentals

1-day range
$35.88$36.87
Market cap
$45.34B
P/E (trailing)
69.38
P/E (forward)
23.19
EPS (trailing)
$0.84
Dividend yield
—
Beta
0.95
Avg. volume
7.66M
52-week range
$31.49$50.88
Next earnings: November 4, 2026 · EPS estimate $0.35confirmed

How Medline Inc. Class A Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$28.43BNet Income$1.16B (4%)Cost of Revenue$20.91B (74%)SG&A$4.52B (16%)Other$1.74B (6%)Tax$91.00M (0%)MDLN

Source: 10-K filed Feb 25, 2026 · via SEC EDGAR / Finnhub

Gross Profit$7.52B(26%)
Operating Income$2.21B(8%)

Forecasts

26 analyst ratings

Buy 79%
Hold 21%
Sell 0%
1-year price forecast
High
$55
+53.0%
Median
$45
+25.2%
Low
$34
-5.4%

Medline Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

  • MDLN
    Medline Inc. Class A Common Stock
    $35.96
    ▼ 1.67%
    Market cap $45.34BP/E 69.38
    $31.49$50.88
  • BDX
    Becton Dickinson and Company Common Stock
    $191.75
    ▼ 1.04%
    Market cap $48.79BP/E 54.13
    $127.59$193.07
  • RMD
    ResMed Inc. Common Stock
    $238.97
    ▼ 1.35%
    Market cap $32.38BP/E 22.23
    $180.27$277.67
  • DXCM
    DexCom Inc. Common Stock
    $86.04
    ▼ 1.90%
    Market cap $31.33BP/E 32.73
    $54.11$92.59
  • WST
    West Pharmaceutical Services Inc. Common Stock
    $384.02
    ▲ 0.26%
    Market cap $24.53BP/E 48.71
    $223.83$386
  • BSX
    Boston Scientific Corporation Common Stock
    $44.39
    ▲ 0.57%
    Market cap $71.45BP/E 17.32
    $41.39$105.65
  • BAX
    Baxter International Inc. Common Stock
    $25.28
    ▼ 1.86%
    Market cap $13.96BP/E —
    $15.73$30

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
1.35M
Disposed
25.62M

Institutional Ownership

March 31, 2026

Total shares held
621.79M
Total value held
$27.17B
Institutional holders
306
Top holders this quarter
  • Unknown187.08M
  • Unknown86.47M
  • Unknown36.56M
  • Unknown23.16M
  • Unknown20.96M
  • Unknown16.92M
  • Unknown15.70M
  • Unknown14.73M
  • Unknown11.79M
  • Unknown11.57M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.